← Leaderboards
Caleb Nathaniel Fischer
Vanderbilt University
$120,264
Attributed
$120,264
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61.6K · FY2018–19$100K$75K$50K$25K$0
'18
'19
Funding mix
By agency
NIH$120,264 · 1
By mechanism
F32$120,264 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Brian O Bachmann$7,858,203
- Thao P Dang$2,998,297
- Fang Yan$6,907,181
- David I Greenstein$16,287,455
- Jonathan Michael Irish$4,589,394
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsApoptosisBaseBenchmarkingBiologicalBiologyBurkholderiaCancer CellCancer TherapyCell LineCell PhysiologyCellsCellular AssayCellular TargetingColumn ChromatographyComparativeCompetitive EnvironmentCuesDictyosteliumDna DamageDrug DiscoveryEcosystemEmerging Antibiotic ResistanceActinobacteria Class